"A family of three patents surrounding Veyonda, including one pertaining to use with chemotherapy, has entered the global national phase following a review by the International Examiner."
and what has the International examiner said in its review?
Not the first initial opinion, but now a chapter 1 examination. I suggest you go look them up yourself. Easy to find.
Here is one to start with (IB/373) International Preliminary Report on Patentability Chapter I on (WO2017181242) CHEMOTHERAPY IMPROVEMENTS claims 1-28 inventive step NONE.
https://patentscope.wipo.int/search...ing=FP:(noxopharm)&recNum=2&maxRec=12
"A family of three patents surrounding Veyonda, including one...
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 52445 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 14000 | 1 |
View Market Depth
| Last trade - 10.11am 27/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable
